<DOC>
	<DOC>NCT00788840</DOC>
	<brief_summary>This is a study designed to compare the effects of 2 long-acting insulins, detemir and insulatard, on energy expenditure,weight, fat composition, gut hormone profiles, glycaemic control and fat and muscle gene expression over a 6 month period.</brief_summary>
	<brief_title>Detemir Energy Expenditure Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Isophane insulin, beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Isophane Insulin, Human</mesh_term>
	<mesh_term>Insulin, Isophane</mesh_term>
	<criteria>1. Type 2 diabetes 2. Treated with metformin 3. Already on treatment with a longacting or intermediate insulin. 4. Over 18 years of age, 5. HbA1c &gt; 7.0% 6. BMI 2740 7. Able and willing to perform selfblood glucose monitoring. 8. Able and willing to maintain consistent eating habits throughout the entire trial period. 9. Able and willing to maintain consistent physical activity level during the entire trial period 1. Patients on sulphonylureas or thiazolidinediones 2. Proliferative retinopathy that has required acute treatment within the last six months. 3. Impaired hepatic or renal functions. 4. Cardiac problems. 5. Uncontrolled hypertension (treated or untreated). 6. Mental incapacity, unwillingness or a language barrier precluding adequate understanding or cooperation.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>